AMANDA KURTZ: Open Payments
NPI 1659680916 · HALLETTSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 17 payments from 7 companies in 2025. Trend: 2023 $97 · 2024 $174 · 2025 $445
Food & beverage: $345Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $205 |
| GENZYME CORPORATION | 3 | $80 |
| UCB, Inc. | 3 | $72 |
| Galderma Laboratories, L.P. | 1 | $41 |
| Lilly USA, LLC | 1 | $17 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: TREMFYA, DUPIXENT, Bimzelx, NEMLUVIO, TALTZ, Cabtreo, COSENTYX.
Industry payments across TX — which companies pay providers there.
